#USA #healthcare #Amsino #Pomona #ampiezza

Amsino International Partners with ampiezza for Enhanced Healthcare Supply

Amsino International, Inc., a recognized leader in manufacturing single-use medical devices, has recently forged a vital collaboration with ampiezza, a prominent aggregation group under the auspices of Vizient. This partnership, effective from December 1, 2025, ensures that healthcare systems associated with ampiezza can access competitive pricing for Amsino's suite of pre-filled flush syringes.

Expanding Member Choice

Under the terms of this agreement, Amsino positions itself as a favored vendor within the ampiezza network — one that comprises over 90 health systems across North America. This development not only diversifies the available options for healthcare providers but also guarantees a reliable supply of high-quality flush syringes, aligning with the pressing needs of medical professionals. Jeff Reid, President of Amsino North America, expressed optimism about this collaboration, emphasizing the commitment to delivering consistent and dependable healthcare solutions.

Focus on Quality and Supply Resilience

Amsino's pre-filled flush syringes are integral to maintaining safe vascular access within various clinical environments. Each product in their line is meticulously engineered to enhance clinician workflow and ensure continuity of supply. Noteworthy configurations featured under this partnership include:

• - 3705-3US1: A North American-made pre-filled flush syringe designed for resilience and faster supply times.
• - 3705CUS: A sterile-field-ready flush syringe that prioritizes both safety and efficiency, also produced in North America.

This expansion of offerings reinforces Amsino’s dedication to not only meeting but exceeding the safety and operational requirements of healthcare providers.

Implications for Healthcare Providers

The partnership marks a significant stride in addressing the challenges faced by healthcare systems, particularly in the realms of supply chain management and product accessibility. With the assurance of continuity and clinical performance of Amsino's flush syringes, providers can focus on delivering optimal patient care without the burden of supply issues.

Additionally, Amsino has been enhancing its manufacturing capabilities, a strategic move that further secures its position in the market. The increased production capacity is crucial for ensuring that the partnership with ampiezza results in a tangible impact on healthcare delivery across the involved systems.

About Amsino International

Amsino International is dedicated to creating innovative medical devices that span various healthcare categories, including medication delivery and surgical supplies. Their mission is clear: to supply high-value, safe, and efficient products that support healthcare professionals and their patients. The recent manufacturing expansions are pivotal as they bolster Amsino's capacity to serve its partners effectively, particularly in challenging times marked by global supply uncertainties.

The agreement is now in full effect, allowing ampiezza members to utilize their standard Vizient contracting channels to access detailed product information and pricing. As the healthcare landscape continues to evolve, partnerships like these play an essential role in navigating challenges and ensuring that quality care remains accessible for all.